FAM99A and hepatocellular carcinoma: FAM99A was also found to be upregulated upon treatment of cancerous hepatocytes (HBL‐derived Hep‐G2 and HCC‐derived HCCLM3) by icaritin—a natural chemotherapeutical agent isolated from Epimedium plants which was under clinical trials for HCC therapy [113].